We concurrently showed that MM cells up-regulated HAPLN1 synthesis and matrix metalloproteinase 2 activity in BMSCs to promote the generation of this matrikine and cause drug resistance. The gene discussed is HAPLN1; the disease is Miyoshi myopathy.